Pharmazz India Private Limited
Legal Status of Firm
Limited Company (Ltd./Pvt.Ltd.)
Year of Establishment
2010
Annual Turnover
Upto Rs. 50 Lakh
Indiamart Member Since
Apr 2011
Diagnostic Imaging Of Solid Tumors
- A biotechnology product that transiently alters the image of malignant but not benign solid tumors.
- Potential global market size of about $5.3 billion.
* PMZ-1620 can be used to differentiate between a benign and a malignant tumor.
* In patients with breast cancer intravenous administration of PMZ-1620 shows a specific increase in tumor vessel diameter compared to baseline along with a corresponding decrease in resistive index.
* Patents granted in European Union (EP 05824775.0) and India (IP 243532); pending in other countries.
* Clinical stage – Phase II/III human studies planned.
* Link to publications
Product Details
Company Details
Product Description
- A biotechnology product that transiently alters the image of malignant but not benign solid tumors.
- Potential global market size of about $5.3 billion.
- PMZ-1620 can be used to differentiate between a benign and a malignant tumor.
- In patients with breast cancer intravenous administration of PMZ-1620 shows a specific increase in tumor vessel diameter compared to baseline along with a corresponding decrease in resistive index.
- Patents granted in European Union (EP 05824775.0) and India (IP 243532); pending in other countries.
- Clinical stage – Phase II/III human studies planned.
- Link to publications
About the Company
Established in 2010, Pharmazz Inc. is an emerging global pharmaceutical company. Focus of the company is to discover, acquire, develop and market novel pharmaceutical products for use in critical care and hospital settings.
Pharmazz conducts studies that lead to the discovery and development of products for the diagnosis and treatment of clinical conditions that require critical care and hospital settings.
The company conducts regulatory studies with the aim of getting market approval of novel drugs or expanding the market size of commercialized products.
Pharmazz constantly assesses global healthcare developments and strategically positions its products to maximize benefit and use for patients.
Pharmazz has established a fully owned subsidiary in India (Pharmazz India Private Limited) and in UK (Pharmazz UK Limited).
Seller Contact Details
H-6, Site-c, Surajpur Industrial Area, Greater Noida - 201307, Gautam Budh Nagar, Uttar Pradesh, India
Get Directions